John C. Moran is Director at Anika Therapeutics, Inc. (ANIK). They have made 5 open-market trades across 1 company since 2013, most recently 2015-08-07.
CIK 0001383662
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIK | SELL | 2015-08-07 | 2015-08-11 | $36.18 | $72K | -2.0% | +1.5% | +1.5% |
| ANIK | SELL | 2015-05-27 | 2015-05-29 | $33.00 | $83K | -2.0% | +1.5% | +1.5% |
| ANIK | SELL | 2015-02-26 | 2015-03-02 | $39.61 | $99K | -2.0% | +1.5% | +1.5% |
| ANIK | SELL | 2014-05-30 | 2014-06-03 | $48.41 | $97K | -2.0% | +1.5% | +1.5% |
| ANIK | SELL | 2013-08-22 | 2013-08-26 | $24.35 | $122K | -2.0% | +1.5% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.